# Foundation Medical Partners

> Foundation Medical Partners is a VC fund in Norwalk backing Health Care and Medical Device. See 28 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Norwalk, United States
- Total investments: 28
- Last investment: Jan 2015
- Lead investor: 7%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/flare-capital
- Website: http://www.foundmed.com/

Foundation Medical Partners is a team of proven healthcare technology venture capital investors known for delivering unparalleled strategic industry resources, insight and a total commitment to the success of the entrepreneurs with whom they have the privilege of partnering.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 36% |
| Medical Device | 7 | 25% |
| Medical | 5 | 18% |
| Biotechnology | 4 | 14% |
| Manufacturing | 4 | 14% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series E | 4 | 14% |
| Series B | 3 | 11% |
| Series C | 3 | 11% |
| Funding Round | 3 | 11% |
| Series A | 2 | 7% |

9 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EndoGastric Solutions | EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington. | $50M |  | Dec 01, 2015 |  |
| Iora Health | Iora Health is dedicated to providing possible service and care for each patient without any of the barriers or excuses that plague the current system. They’ve completely redesigned Primary Care to help patients better manage their health and navigate the health care system. Every patient gets a personal physician as well as a personal health coachwho stays in close contact during and between office visits, both of whom are available by email, text, or video in addition to in-person visits. In addition, they provide educational offerings, including group visits, to help patients stay on track with their health goals. | $28M | Series C | Jan 26, 2015 |  |
| EndoGastric Solutions | EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington. | $30M | Series G | May 06, 2014 |  |
| IlluminOss Medical | IlluminOss Medical, Inc. is a commercial-stage medical device company offering a unique, minimally invasive technology for fracture repair and stabilization. The Company utilizes a light-curable polymer contained within an expandable balloon to create a patient-conforming intramedullary implant for bone stabilization. The revolutionary, minimallyinvasive technology is particularly applicable for repair and treatment of patients with osteoporotic and compromised bone. The IlluminOss system is CE-marked and FDA-cleared for a variety of anatomical sites, with further indications pending. | $28M | Series C | Sep 27, 2012 |  |
| EndoGastric Solutions | EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington. | $13M |  | Jun 21, 2012 |  |
| Direct Flow Medical | Direct Flow Medical is a medical device company developing a percutaneous aortic tissue valve prosthesis to provide patients requiring treatment of cardiac valve insufficiency with a safe and effective percutaneous option. Approximately 1.2 million people over the age of 65 have calcified aortic valves, yet only an estimated 150,000 are surgicallytreated each year. | $284K |  | Apr 01, 2012 |  |
| EndoGastric Solutions | EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington. | $2.1M |  | Apr 01, 2012 |  |
| EndoGastric Solutions | EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0procedure—a minimally invasive solution that addresses a significant unmet clinical need.EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington. | $10.9M | Series G | Mar 21, 2012 |  |
| Explorys | Explorys provides a secure cloud-computing platform specialized for the healthcare industry. We empower our customers to accelerate research and product development, while enabling critical measurement for healthcare reform, performance management and protocol safety. | $11.5M | Series C | May 10, 2011 |  |
| Spine Wave | Spine Wave engages in developing and marketing medical devices for the treatment of spinal disorders. It focuses on commercializing technology platforms that offer surgical solutions for spine surgeons and their patients. Spine Wave offers expandable PEEK spacers and expandable interbody devices for posterior surgery; pivoting spacer systems;lateral spacer systems, XDL expandable devices, and lateral access systems for lateral stabilization; Leva PX, an expandable interbody device for the treatment of spinal disorders; GraftMag Graft Delivery System to deliver large amounts of bone graft; and fixation products such as spine systems for treating degeneration, deformity, tumor, and trauma of the thoracolumbar spine as well as adjacent level systems. Spine Wave also offers anterior cervical plate systems that provide stabilization as an adjunct to spinal fusion from C2-C7 through anterior screw fixation; and cervical spacer systems to treat degenerative disc disease from C2-T1. It offers its products through distributors. John Pafford and Mark LoGuidice founded Spine Wave on February 1, 2001. It has its headquarters in Shelton in Connecticut. | $17.5M | Series E | Feb 02, 2011 |  |

10 of 28 investments shown.

## Co-investors
- [Advanced Technology Ventures](https://shizune.co/investors/profile/advanced-technology-ventures) — VC Fund, 9 deals together
- [Boston Millennia Partners](https://shizune.co/investors/profile/boston-millennia-partners) — VC Fund, 7 deals together
- [DeNovo Ventures](https://shizune.co/investors/profile/denovo-ventures) — VC Fund, 7 deals together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 6 deals together
- [Chicago Growth Partners](https://shizune.co/investors/profile/chicago-growth-partners) — VC Fund, 6 deals together
- [Radius Ventures](https://shizune.co/investors/profile/radius-ventures) — VC Fund, 6 deals together

## Similar investors

### Similar stage
- [Krungsri Finnovate](https://shizune.co/investors/profile/krungsri-finnovate) — VC Fund
- [Munich Venture Partners](https://shizune.co/investors/profile/munich-venture-partners) — VC Fund
- [yet2Ventures](https://shizune.co/investors/profile/yet2ventures) — VC Fund

## FAQ

### What does Foundation Medical Partners invest in?

Foundation Medical Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Series E and Series B stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Foundation Medical Partners last invest?

The most recent investment recorded for Foundation Medical Partners closed in Jan 2015. Shizune tracks 28 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co